Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRevenue (Gross)
Ratios

Abeona Therapeutics (ABEO) Long-Term Debt Issuances (2020 - 2024)

Abeona Therapeutics has reported Long-Term Debt Issuances over the past 2 years, most recently at $20.0 million for Q1 2024.

  • Quarterly results put Long-Term Debt Issuances at $20.0 million for Q1 2024, changed N/A from a year ago — trailing twelve months through Dec 2024 was $20.0 million (changed N/A YoY), and the annual figure for FY2024 was $20.0 million, changed.
  • Long-Term Debt Issuances for Q1 2024 was $20.0 million at Abeona Therapeutics, up from -$42000.0 in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for ABEO hit a ceiling of $20.0 million in Q1 2024 and a floor of -$42000.0 in Q2 2020.